Vol. 61 No. 4 (2022): Acta Oncologica

Articles

• Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study

  Guro Falk Eriksen, Jūratė Šaltytė Benth, Bjørn Henning Grønberg, Siri Rostoft, Lene Kirkhus, Øyvind Kirkevold, Anne Hjelstuen, Marit Slaaen

  393-402

  Published: 2022-04-03

  • PDF

• A randomized phase-II study of reirradiation and hyperthermia versus reirradiation and hyperthermia plus chemotherapy for locally recurrent breast cancer in previously irradiated area

  Daphne Schouten, Rob van Os, Anneke M. Westermann, Hans Crezee, Geertjan van Tienhoven, M. Willemijn Kolff, Adriaan D. Bins

  441-448

  Published: 2022-04-03

  • PDF

• Radiofrequency ablation vs radiation therapy vs transarterial chemoembolization vs yttrium 90 for local treatment of liver cancer – a systematic review and network meta-analysis of survival data

  Ronald Chow, Charles B. Simone II, Meghan Pooja Jairam, Anand Swaminath, Gabriel Boldt, Michael Lock

  484-494

  Published: 2022-04-03

  • PDF

• MECOM gene overexpression in pediatric patients with acute myeloid leukemia

  Mariam Elsherif, Mahmoud Hammad, Hanafy Hafez, Dina Yassin, Mohamed Ashraf, Nouran Yasser, Leslie Lehmann, Alaa Elhaddad

  516-522

  Published: 2022-04-03

  • PDF

• Annual surgeon and hospital volume of gastrectomy and gastric adenocarcinoma survival in a population-based cohort study

  Johannes Asplund, Fredrik Mattsson, Magdalena Plecka-Östlund, Sheraz R. Markar, Jesper Lagergren

  425-432

  Published: 2022-04-03

  • PDF

• Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer

  Randal H. Henderson, Curtis M. Bryant, R. Charles Nichols, William M. Mendenhall, Bradford S. Hoppe, Zhong Su, Christopher G. Morris, Nancy P. Mendenhall

  468-477

  Published: 2022-04-03

  • PDF

• Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

  Andreas Glenthøj, Lasse H. Jakobsen, Mads Emil Bjørn, Christian B. Poulsen, Henrik Sengeløv, Marianne T. Severinsen, Kristian Qvist, Ulrik M. Overgaard, Syed A. Ahmad, Annika Rewes, Ingolf Mølle, Casper N. Strandholdt, Annette R. Kodahl, Jesper Ryg, Christian Brieghel, Isik S. Johansen, Karina Kannik, Søren Jensen-Fangel, Lothar Wiese, Ole Kirk, Michael R. Clausen, Marie Helleberg, Henrik Frederiksen

  500-504

  Published: 2022-04-03

  • PDF

• Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

  Mette T. Mouritzen, Karen F. Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W. M. Nielsen, Anna Livbjerg, Jacob W. Larsen, Halla Skuladottir, Charlotte Kristiansen, Kim Wedervang, Tine Schytte, Karin H. Hansen, Anne-Cathrine Østby, Malene S. Frank, Jakob Lauritsen, Jens B. Sørensen, Seppo W. Langer, Gitte F. Persson, Jon L. Andersen, Pernille H. Homann, Emilie B. Kristensen, Lars B. Drivsholm, Martin Bøgsted, Heidi S. Christensen, Mette Pøhl, Birgitte Bjørnhart

  409-416

  Published: 2022-04-03

  • PDF

• The impact of tobacco smoking on survival of patients with oral squamous cell carcinoma: a population-based retrospective study

  Amanda Oester Andersen, Jakob Schmidt Jensen, Kathrine Kronberg Jakobsen, Helene Stampe, Kristoffer Juul Nielsen, Irene Wessel, Anders Christensen, Elo Andersen, Jeppe Friborg, Christian Grønhøj, Christian von Buchwald

  449-458

  Published: 2022-04-03

  • PDF

• Comparing treatment modalities for hepatocellular carcinoma: the value of network meta-analyses

  Ronald Chow, Charles B. Simone II, Meghan Pooja Jairam, Anand Swaminath, Gabriel Boldt, Michael Lock

  495

  Published: 2022-04-03

  • PDF

• Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives

  Cecilia Merk, Anna Martling, Johan Lindberg, Léonor Benhaim, Julien Taieb, Pehr Lind

  523-530

  Published: 2022-04-03

  • PDF

• Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer

  Anukriti Singh, Waqar Haque, Henry S. Park, Bin S. Teh, E. Brian Butler, Ming Zeng, Steven H. Lin, James W. Welsh, Joe Y. Chang, Vivek Verma

  403-408

  Published: 2022-04-03

  • PDF

• Base of tongue squamous cell carcinomas, outcome depending on treatment strategy and p16 status. A population-based study from the Swedish Head and Neck Cancer Register

  Anders Högmo, Erik Holmberg, Hedda Haugen Cange, Johan Reizenstein, Johan Wennerberg, Martin Beran, Karin Söderkvist, Eva Hammerlid, Helena Sjödin, Lovisa Farnebo, Karl Sandström, Lalle Hammarstedt-Nordenvall, Katarina Zborayova, Eva Brun

  433-440

  Published: 2022-04-03

  • PDF

• Long-term survival after treatment for primary anal cancer– results from the Swedish national ANCA cohort study

  Mia Johansson, Anna Axelsson, Eva Haglind, David Bock, Eva Angenete

  478-483

  Published: 2022-04-03

  • PDF

• Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma

  Mingyuan Zou, Chen Zhang, Yan Sun, Huina Wu, Feng Xiao, Wei Gao, Fengfeng Zhao, Xiaobo Fan, Guoqiu Wu

  505-515

  Published: 2022-04-03

  • PDF

• How breast cancer recurrences are found – a real-world, prospective cohort study

  Sylvia Myller, Arja Jukkola, Anniina Jääskeläinen, Nelli Roininen, Peeter Karihtala

  417-424

  Published: 2022-04-03

  • PDF

• Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer

  Yara van Holstein, Stella Trompet, Floor J. van Deudekom, Barbara van Munster, Nienke A. de Glas, Frederiek van den Bos, Anna Uit den Boogaard, Marjan J. T. van der Elst, Marleen A. E. van der Kaaij, Karen J. Neelis, Alexandra M. J. Langers, Marije Slingerland, Johanneke E. A. Portielje, Simon P. Mooijaart

  459-467

  Published: 2022-04-03

  • PDF

• Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation

  Pierre Loap, Alfredo Mirandola, Ludovic De Marzi, Viviana Vitolo, Amelia Barcellini, Alberto Iannalfi, Rémi Dendale, Youlia Kirova, Ester Orlandi

  496-499

  Published: 2022-04-03

  • PDF